Jakub Gumprecht

1.1k total citations · 1 hit paper
25 papers, 733 citations indexed

About

Jakub Gumprecht is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Jakub Gumprecht has authored 25 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Economics and Econometrics. Recurrent topics in Jakub Gumprecht's work include Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiovascular Function and Risk Factors (4 papers). Jakub Gumprecht is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiovascular Function and Risk Factors (4 papers). Jakub Gumprecht collaborates with scholars based in Poland, United Kingdom and Denmark. Jakub Gumprecht's co-authors include Gregory Y.H. Lip, Marco Proietti, Wern Yew Ding, Monika Kozieł, Daniele Pastori, José Miguel Rivera‐Caravaca, Danilo Menichelli, Ying X. Gue, Yutao Guo and Pil‐Sung Yang and has published in prestigious journals such as Scientific Reports, Thrombosis and Haemostasis and Diabetes Obesity and Metabolism.

In The Last Decade

Jakub Gumprecht

24 papers receiving 704 citations

Hit Papers

Adherence to the ‘Atrial Fibrillation Better Care’ Pathwa... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients
    2021 275 citations Daniele Pastori, Wern Yew Ding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jakub Gumprecht Poland 11 418 241 160 92 82 25 733
Jia‐Rou Liu Taiwan 16 345 0.8× 184 0.8× 110 0.7× 17 0.2× 73 0.9× 36 652
Chloe A. Allen Maycock United States 8 317 0.8× 99 0.4× 208 1.3× 57 0.6× 39 0.5× 11 527
Maximilian Brockmeyer Germany 10 249 0.6× 72 0.3× 358 2.2× 136 1.5× 25 0.3× 28 600
А. И. Ершова Russia 13 221 0.5× 93 0.4× 188 1.2× 37 0.4× 42 0.5× 98 487
Donatella Ruggiero Italy 13 389 0.9× 134 0.6× 188 1.2× 100 1.1× 43 0.5× 19 645
Volker Schulze Germany 12 556 1.3× 70 0.3× 584 3.6× 140 1.5× 31 0.4× 31 984
Bert D. Dikkeschei Netherlands 14 246 0.6× 164 0.7× 289 1.8× 15 0.2× 87 1.1× 23 650
Rahman Shah United States 13 426 1.0× 44 0.2× 281 1.8× 66 0.7× 52 0.6× 50 680
Keith Sai Kit Leung United Kingdom 15 288 0.7× 156 0.6× 89 0.6× 16 0.2× 94 1.1× 41 645
George F. Wohlford United States 15 552 1.3× 105 0.4× 216 1.4× 25 0.3× 262 3.2× 32 923

Countries citing papers authored by Jakub Gumprecht

Since Specialization
Citations

This map shows the geographic impact of Jakub Gumprecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Gumprecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Gumprecht more than expected).

Fields of papers citing papers by Jakub Gumprecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Gumprecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Gumprecht. The network helps show where Jakub Gumprecht may publish in the future.

Co-authorship network of co-authors of Jakub Gumprecht

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Gumprecht. A scholar is included among the top collaborators of Jakub Gumprecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Gumprecht. Jakub Gumprecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gumprecht, Jakub, Gregory Y.H. Lip, Adam Sokal, et al.. (2023). Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65. Scientific Reports. 13(1). 17252–17252. 1 indexed citations
2.
Gumprecht, Jakub & Zbigniew Kalarus. (2022). ATRIAL FIBRILLATION IN PATIENTS WITH CONCOMITANT DIABETES MELLITUS – WHAT DO WE ALREADY KNOW AND WHAT DO WE NEED TO DISCOVER?. Wiadomości Lekarskie. 75(1). 123–127. 1 indexed citations
3.
Pastori, Daniele, Danilo Menichelli, Jakub Gumprecht, et al.. (2021). The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients. EP Europace. 23(Supplement_3). 4 indexed citations
4.
5.
6.
Li, Yan‐Guang, Jakub Gumprecht, Nidal Asaad, et al.. (2020). One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry. International Journal of Cardiology. 302. 47–52. 8 indexed citations
7.
Gumprecht, Jakub, et al.. (2020). Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials. European Heart Journal Supplements. 22(Supplement_I). I1–I12. 4 indexed citations
8.
Gumprecht, Jakub, Yan‐Guang Li, Marco Proietti, et al.. (2020). Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry. European Journal of Clinical Investigation. 51(3). e13385–e13385. 13 indexed citations
9.
Gumprecht, Jakub, et al.. (2019). Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management. Journal of Human Hypertension. 33(12). 824–836. 65 indexed citations
10.
Gumprecht, Jakub, et al.. (2019). Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation. Journal of Cardiovascular Pharmacology. 74(6). 491–498. 10 indexed citations
11.
Gumprecht, Jakub, et al.. (2019). A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention. Expert Opinion on Drug Safety. 18(12). 1119–1125. 2 indexed citations
12.
Lenarczyk, Radosław, Jakub Gumprecht, Ewa Jędrzejczyk‐Patej, et al.. (2018). Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices. Kardiologia Polska. 76(7). 1081–1088. 11 indexed citations
13.
Nabrdalik, Katarzyna, et al.. (2017). Amelioration of liver function and glucose control with pioglitazone in a patient with diabetes mellitus type 2 and nonalcoholic fatty liver disease. Clinical Diabetology. 5(6). 199–202. 1 indexed citations
14.
Gumprecht, Jakub, Masahiko Gosho, Dragos Budinski, & Neil Hounslow. (2011). Comparative long‐term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. Diabetes Obesity and Metabolism. 13(11). 1047–1055. 68 indexed citations
15.
16.
Pluskiewicz, Wojciech, Joanna Żywiec, & Jakub Gumprecht. (2009). Spine Bone Mineral Density in Subjects after Renal Transplantation Compared with End-stage Renal Failure and Healthy Subjects. Hormone and Metabolic Research. 41(7). 563–567. 1 indexed citations
17.
Benroubi, Marian, Vito Borzı̀, Jakub Gumprecht, et al.. (2009). Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study. International Journal of Clinical Practice. 63(4). 574–582. 36 indexed citations
18.
Nauck, M., et al.. (2006). Five Weeks of Treatment with the GLP-1 Analogue Liraglutide Improves Glycaemic Control and Lowers Body weight in Subjects with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 114(8). 417–423. 111 indexed citations
19.
Rogala, Barbara, et al.. (1995). Platelet aggregation in IgE-mediated allergy with elevated soluble Fc epsilon RII/CD23 level.. PubMed. 5(3). 161–5. 10 indexed citations
20.
Gumprecht, Jakub, et al.. (1993). [Platelet function in patients with diabetes mellitus].. PubMed. 89(4). 321–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia‐Rou Liu Breakdown of academic impact, for papers by Chloe A. Allen Maycock Breakdown of academic impact, for papers by Maximilian Brockmeyer Breakdown of academic impact, for papers by А. И. Ершова Breakdown of academic impact, for papers by Donatella Ruggiero Breakdown of academic impact, for papers by Volker Schulze Breakdown of academic impact, for papers by Bert D. Dikkeschei Breakdown of academic impact, for papers by Rahman Shah Breakdown of academic impact, for papers by Keith Sai Kit Leung Breakdown of academic impact, for papers by George F. Wohlford
Rankless by CCL
2026